Innovative gene therapy trial for Parkinson's disease

(University College London) A trial for a new gene therapy, known as AXO-Lenti-PD, aimed at improving the supply of dopamine in the brains of people with Parkinson's disease has been launched by researchers at UCL and University College London Hospitals (UCLH).
Source: EurekAlert! - Biology - Category: Biology Source Type: news